IL-PROJECT44
11.6.2020 13:02:07 CEST | Business Wire | Press release
project44 , the global leader in advanced visibility for shippers and logistics service providers, today announced the industry’s first Global Preferred Carriers Program . This program evaluates and recognizes — through a monthly published list — less-than-truckload (LTL) and truckload carriers in the project44 network that have demonstrated excellence in performance, consistency, delivery of high-fidelity data and shipment visibility across multiple loads.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200611005018/en/
Through this program, global retailers, manufacturers and distributors can benefit from more predictable and higher service levels and increased network stability. Preferred carriers have the advantage of gaining additional business opportunities from over 300 enterprise customers, representing $57B of managed freight, and more strategic, multiyear relationships.
“Markets will always have their ups and downs, and we have to stay agile and productive regardless. Real-time visibility empowers us to add more value to our customers by keeping their costs consistent and shipments predictable,” said Bartłomiej Wędzikowski of Wedzikowski Transport, a leading European truckload carrier headquartered in Poland. “We’re confident that our standing in project44’s Preferred Carriers list will send a direct signal to our customers that we are committed to their business success.”
project44 Preferred Carriers include 9 LTL carriers in North America and 320 truckload carriers, including Top200 in Europe, Top100 in North America, and Top20 in Latin America. Each of these 329 carriers demonstrated best in class performance levels and exceeded their customers’ expectations for real-time visibility.
Those included on the list are awarded with the tracking compliance badge representing that a particular carrier has met project44’s rigorous tracking standards, including high tracking percentages across multiple loads, consistent delivery of high-fidelity data, and commitment to real-time shipment visibility. Some of the pioneering carriers reaching Preferred status in May include Saia and Averitt Express on the LTL list and DSV and CR England on the truckload list.
“project44 enables LTL carriers to eliminate manual processes and increase efficiency,” said Marek Bella, leader of Europe Carrier Operations at project44. “Our data shows that truckload carriers visible on the project44 network are four times more likely to win freight and new customers.”
“We’re very proud to be recognized as a project44 Preferred Carrier. Capacity is tight, and trucking conditions have been changed dramatically and rapidly,” said Wendi Fitzsimmons, Project and IT Manager at Volpe Dedicated, a North American carrier with nearly 100 years of truckload experience. “With a streamlined data sharing process, we were able to provide a competitive customer experience by balancing pricing and on-time delivery. As a result, we’re equipped to bypass transactional interactions and invest our resources in building long-term strategic partnerships with our customers.”
“Our customer’s experience is central to our roadmap and DNA,” said Tommy Barnes, Head of Global Network Partnerships at project44. “By introducing the first global Preferred Carriers program, we want to help the entire transportation ecosystem drive more operational efficiencies and delivery excellence within the entire supply chain.”
To usher in a new era of trust and predictability, project44 has built the most expansive multimodal network, five times larger than any other visibility provider. With the recent launch of the industry’s first and only unified multimodal visibility offering , frictionless collaboration and fast time to value has become a reality.
Learn more about project44 or schedule a demo today.
About project44
project44 is the world’s leading advanced visibility platform for shippers and logistics service providers. project44 connects, automates, and provides visibility into key transportation processes to accelerate insights and shorten the time it takes to turn those insights into actions. Leveraging the power of the project44 cloud-based platform, organizations increase operational efficiencies, reduce costs, improve shipping performance, and deliver an exceptional Amazon-like experience to their customers. Connected to thousands of carriers worldwide and having comprehensive coverage for all ELD and telematics devices on the market, project44 supports all transportation modes and shipping types, including Air, Parcel, Final-Mile, Less-than-Truckload, Volume Less-than-Truckload, Groupage, Truckload, Rail, Intermodal, and Ocean. project44 has placed second, behind only Amazon, on FreightWaves’ 2020 Freight Tech 25, a list of the most innovative companies across the freight industry, and received the 2020 SAP® Pinnacle Award as the Cloud Partner Integration of the Year. To learn more, visit www.project44.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200611005018/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom